JOMOL THOMAS: Open Payments
NPI 1306371992 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$635 in 16 payments from 8 companies in 2025. Trend: 2023 $480 · 2024 $633 · 2025 $635
Food & beverage: $352Education: $283
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $135 |
| Incyte Corporation | 2 | $125 |
| SEAGEN INC. | 1 | $83 |
| Celgene Corporation | 3 | $79 |
| Janssen Scientific Affairs, LLC | 2 | $74 |
| BTG International Inc. | 3 | $62 |
| ADC THERAPEUTICS AMERICA, INC. | 2 | $48 |
| Karyopharm Therapeutics Inc. | 1 | $29 |
Products named: VORAXAZE, REBLOZYL, ZYNLONTA, CARVYKTI, DARZALEX, JAYPIRCA, XPOVIO, MONJUVI.
Industry payments across TX — which companies pay providers there.
